Criteria for screening tests for gestational diabetes

Area of Science:

• Obstetrics and Gynecology
• Endocrinology
• Clinical Chemistry

Background:

• Gestational diabetes mellitus (GDM) poses risks to maternal and fetal health.
• Accurate screening and diagnosis are crucial for effective management.
• Current diagnostic criteria may require refinement for optimal detection.

Purpose of the Study:

• To evaluate the effectiveness of current glucose screening test thresholds for diagnosing gestational glucose intolerance.
• To determine optimal plasma glucose levels for identifying pregnant women requiring further glucose tolerance testing.
• To propose adjustments to screening thresholds for improved GDM detection.

Main Methods:

• A 50 gm, 1-hour glucose screening test was administered to 381 pregnant women aged 25+.
• Women with plasma glucose ≥ 130 mg/dl underwent a 100 gm, 3-hour glucose tolerance test.
• O'Sullivan's diagnostic criteria were used to diagnose gestational glucose intolerance.

Main Results:

• Three diagnostic zones were identified based on screening test values: <135 mg/dl (low diabetes risk), 135-182 mg/dl (uncertainty, requires further testing), and >182 mg/dl (high diabetes risk).
• A plasma glucose level of 135 mg/dl was identified as a more sensitive threshold for further testing.
• The study indicates a potential need to lower the existing screening threshold from 143 mg/dl.

Conclusions:

• Lowering the plasma glucose threshold for further testing from 143 mg/dl to 135 mg/dl may enhance the early identification of gestational glucose intolerance.
• Refining screening protocols can lead to more timely interventions for pregnant women with GDM.
• This adjustment could improve pregnancy outcomes by facilitating earlier management of GDM.